02336nas a2200397 4500000000100000008004100001260001600042653001100058653001100069653000900080653001400089653003000103653002000133653004200153653002700195653006600222653003300288653005600321653002700377653002100404653001600425653006700441653005200508653004300560653006000603653002200663100001900685700001500704700001600719245007100735250001500806300000800821490000700829520105100836020005101887 2014 d c3000673091510aFemale10aHumans10aMale10aPrognosis10aDrug Therapy, Combination10aRisk Assessment10aRandomized Controlled Trials as Topic10aInfusions, Intravenous10aAntihypertensive Agents/ administration & dosage/pharmacology10aBlood Pressure Determination10aCerebral Hemorrhage/complications/diagnosis/therapy10aCritical Care/ methods10aCritical Illness10aEmergencies10aHypertension/ drug therapy/etiology/ mortality/physiopathology10aNervous System Diseases/complications/diagnosis10aStroke/complications/diagnosis/therapy10aSubarachnoid Hemorrhage/complications/diagnosis/therapy10aSurvival Analysis1 aAnderson Craig1 aManning L.1 aRobinson T.00aControl of blood pressure in hypertensive neurological emergencies a2014/04/29 a4360 v163 a
Neurological hypertensive emergencies cause significant morbidity and mortality. Most occur in the setting of ischaemic stroke, spontaneous intracerebral hemorrhage (ICH), or subarachnoid hemorrhage (SAH), but other causes relate to hypertensive encephalopathy and reversible cerebral vasoconstriction syndrome (RCVS). Prompt and controlled reduction of blood pressure (BP) is necessary, although there remains uncertainty as to the optimal rate of decline and ideal antihypertensive agent. There is probably no single treatment strategy that covers all neurological hypertensive emergencies. Prompt diagnosis of the underlying disorder, recognition of its severity, and appropriate targeted treatment are required. Lack of comparative-effectiveness data leaves clinicians with limited evidence-based guidance in management, although significant developments have occurred recently in the field. In this article, we review the management of specific neurological hypertensive emergencies, with particular emphasis on recent evidence.
a1534-3111 (Electronic)